Decreased expression of T-cadherin is associated with gastric cancer prognosis

Hepato-Gastroenterology

Volumn 59, Issue 116, 2012, Pages 1294-1298

  Tang, YaPing ^a   Dai, YingHuan ^a   Huo, JiRong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Gastric cancer; Immunohistochemistry; Prognosis; Real time qPCR; Truncated cadherin; Western blotting

Indexed keywords

CADHERIN; TRUNCATED CADHERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; BLOTTING, WESTERN; CADHERINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84861394043     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12016     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Parkin DM: International variation. Oncogene 2004; 23:6329-6340.
3. Crew KD, Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 2006; 21:354-362.
4. Toyooka S, Toyooka KO, Harada K, et al.: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 2002; 62:3382-3386.
5. Toyooka KO, Toyooka S, Virmani AK, et al.: Loss of expression and aberrant methylation of the CDH13 (H-Cadherin) gene in breast and lung carcinomas. Cancer Res 2001; 61:4556-4560.
6. Zhong Y, Delgado Y, Gomez J, Lee SW, Perez-Soler R: Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin Cancer Res 2001; 7:1683-1687.
7. Andreeva AV, Kutuzov MA: Cadherin 13 in cancer. Genes chromosomes cancer 2010; 49:775-790.
8. Angst BD, Marcozzi C, Magee AI: The cadherin superfamily: diversity in form and function. J Cell Sci 2001; 114:629-641.
9. Ivanov DB, Philippova MP, Tkachuk VA: Structure and functions of classical cadherins. Biochemistry (Mosc) 2001; 66:1174-1186.
10. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996; 2:776-782.
11. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ: A guide and guard: The many faces of T-cadherin. Cell Signal 2009; 21:1035-1044.
12. Takeuchi T, Ohtsuki Y: Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 2001; 16:1287-1293.
13. Kuphal S, Martyn AC, Pedley J, et al.: H-Cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res 2009; 22:296-306.
14. Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, furihata M: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 2009; 583:430-436.
15. Maruyama R, Toyooka S, Toyooka KO, et al.: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001; 61:8659-8663.
16. Kawakami M, Staub J, Cliby W, et al.: Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 1999; 15:715-720.
17. Ehrlich M, Woods CB, Yu MC, et al.: Quantitative analysis of associations between DNA hypermethylation, hypo-methylation and DNMT RNA levels in ovarian tumors. Oncogene 2006; 25:2636-2645.
18. Sato M, Mori Y, Sakurada A, fujimura S, Horii A: The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 1998; 103:96-101.
19. Brock MV, Hooker CM, Ota-Machida E, et al.: DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358:1118-1128.
20. Lee SW, Reimer CL, Campbell DB, et al.: H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 1998; 19:1157-1159.
21. Chan DW, Lee JM, Chan PC, Ng IO: Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer 2008; 123:1043-1052.
22. Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A: Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer 2004; 91:1139-1142.
23. Ai KX, Lu LY, Huang XY, Chen W, Zhang HZ: Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol 2008; 14:1931-1935.
24. Huang ZY, Wu YL, Hedrick N, Gutmann DH: T-cadherin-mediated cell growth regulation involves G(2) phase arrest and requires p21 (CIP1/WAF1) expression. Mol Cell Biol 2003; 23:566-578.
25. Mukoyama Y, Zhou SX, Miyachi Y, Matsuyoshi N: T-Cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J Invest Dermatol 2005; 124:833-838.
26. Lin YL, Sun G, Liu XQ, Chen YG, Zhang CT: Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma. Urol Int 2011; 86:340-345.